Home

VIOSTAN PLUS 160/12.5 - - 30

ATC	B/G	Ingredients	code	Registration Nb	Name	Dosage	Presentation	Form	Route	Agent	Laboratory	Country	Price	Pharmacist Margin	Stratum	Responsible Party Name	Responsible Party Country	Exch_date	%SUBSIDY
C09DA03	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg	7893	186256/13	VIOSTAN PLUS 160/12.5		30	Tablet, film coated	Oral	Benta Trading Co s.a.l.	Benta SAL	Lebanon	668,082 L.L	23.08	A2			03/04/20

ATC	B/G	Ingredients	code	Registration Nb	Name	Presentation	Form	Route	Agent	Laboratory	Country	Price	Pharmacist Margin	Stratum	Responsible Party Name	Responsible Party Country	Exch_date
C09DA03	B	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg	11775	137423/1	CO-DIOVAN	28	Tablet, film coated	Oral	Khalil Fattal & Fils S.A.L.	Novartis Farma SpA	Italy	846,621 L.L	23.08	A2	Novartis Pharma AG	Switzerland	03/04/20
C09DA03	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg	6478	168104/10	ARBITEN PLUS	30	Tablet	Oral	Eva Pharm Plus	Joswe Medical (Jordan Sweden Medical and Sterilization Co)	Jordan	544,256 L.L	23.08	A1			03/04/20
C09DA03	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg	6574	218776/09	CO-ANGINET	30	Tablet, film coated	Oral	Premium Serve Drugstore Co. P.S.D. SAL	The United Pharmaceutical Manufacturing Co Ltd	Jordan	544,256 L.L	23.08	A1	The United Pharmaceutical Manufacturing Co Ltd	Jordan	03/04/20
C09DA03	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg	7935	101814/1	VALUSTAR PLUS	28	Tablet, film coated	Oral	Qualipharm	Atlantic Pharma Producoes Farmaceuticas SA	Portugal	592,635 L.L	23.08	A1	Tecnimede Espana Industria Farmaceutica SA	Spain	03/04/20
C09DA03	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg	8354	096851/12	CO-TABUVAN	30	Tablet, film coated	Oral	Mersaco	Tabuk Pharmaceutical Manufacturing Company	Saudi Arabia	544,256 L.L	23.08	A1	Tabuk Pharmaceutical Manufacturing Company	Saudi Arabia	03/04/20